What is RapidInfo4U?

QUESTION

• Is there a link between vaccinations for Covid-19 & developing Guillain-Barré syndrome?
• Is one type/make of vaccine a higher risk than others?

SHORT ANSWER

Currently, the available evidence does not support a link between COVID-19 vaccination and an increased risk of developing Guillain-Barré syndrome. Isolated cases of Guillain-Barré syndrome have been reported following COVID-19 vaccination but there is no proven association. There are currently no studies that show that the incidence of GBS that occurs following COVID-19 vaccination is greater than the incidence of GBS that normally occurs. Thus, there is currently no evidence to suggest that COVID-19 vaccines increase the risk of developing the syndrome above the natural incidence in a population. Cases of Guillain-Barré syndrome have been reported for different COVID-19 vaccine types. Continued surveillance of adverse events associated with COVID-19 vaccination and epidemiological studies should provide further clarity.

Click here for long answer

The content of this document is correct as of 18/05/2021.

What are the recommended physiotherapy outcome measures to use with Covid-19 patients in an out-patient post-COVID clinical setting?

Question

• What is the evidence to support high flow nasal oxygen in COVID-19 management?
• Does high flow nasal oxygen result in increased droplet dispersion and aerosol generation in COVID-19 patients?

Short Answer

High flow nasal oxygen for the management of COVID-19 is a controversial topic due to a lack of high-quality research into its efficacy and its potential as an aerosol-generating procedure. Systematic reviews commissioned by the World Health Organization found that high-flow nasal cannulas may reduce the need for invasive ventilation and the escalation of treatments over conventional oxygen therapy in COVID-19 patients. However, they caution that this potential advantage must be weighed against the currently unknown risk of droplet and aerosol transmission: there is currently no research evidence directly examining the consequent dispersion of COVID-19 virus for this procedure. A number of actions can reduce any potential risk: deliver HFNO in negative-pressure rooms and/or ensure proper ventilation; use an increased area of precaution; ensure staff have protective PPE; and place surgical masks on patients receiving the HFNO.

The content of this document is correct as of 04/12/20.

QUESTION

• Is there any evidence to suggest chest physiotherapy is an aerosol-generating procedure?
• Does the evidence compare different types of chest physiotherapy treatment techniques – and whether certain treatments may be more aerosol generating than others? (i.e. positive pressure devices, oscillating devices, cough assist, breathing techniques, patient coughing, suction etc).

SHORT ANSWER

There is insufficient evidence to state that chest physiotherapy is an aerosol-generating procedure. However, absence of evidence is not evidence of absence. International and national professional physiotherapy bodies have endorsed guidelines for physiotherapy management during COVID-19 which state that chest physiotherapy interventions are potentially aerosol-generating procedures and strongly recommend using airborne precautions when delivering these interventions. Furthermore, a recent systematic review classified chest physiotherapy interventions as potentially aerosol-generating and recommended, for the purposes of selecting personal protective equipment, that such procedures be treated as aerosol-generating.

The content of this document is correct as of 04/12/20.

Question

What is the latest evidence regarding conscious proning of COVID-19 patients?
At what level of oxygen is it best to commence proning?
When should you stop proning as the patient is improving?

Short Answer

The current evidence for conscious proning is of poor quality and fails to answer several key questions required to inform clinical practice, including the optimum conditions for commencing and ceasing proning. There are multiple RCTs underway that will address these gaps in knowledge over the coming months.

The content of this document is correct as of 27/11/2020.

Question

1.What is current guidance for cleaning a room after a hands-on physiotherapy session?

2.What are the current recommended products for effectively cleaning surfaces?

3.Do I have to wait a certain amount of time to clean my treatment room after a session?

Short answer

1.Clean with detergent and water followed by rinsing and drying. If a surface is suspected or known to have been contaminated by infectious material a disinfected should be used after cleaning.

2.A neutral detergent with water for cleaning and a chlorine-based product, such as sodium hypochlorite, for disinfecting.

3.HSPC cleaning protocols do not stipulate that a certain amount of time should be left between seeing a patient and cleaning. HSPC guidelines state that COVID-19 virus droplets produced by an infected patient will land on surfaces “within minutes” of production. They do not state how many minutes precisely. Research has found that large droplets fall within 1 second while smaller droplets can take up to 9 minutes to fall to the ground.

The content of this answer is correct as of 02/10/2020

QUESTION

• Is there a link between vaccinations for Covid-19 & developing Guillain-Barré syndrome?
• Is one type/make of vaccine a higher risk than others?

SHORT ANSWER

Currently, the available evidence does not support a link between COVID-19 vaccination and an increased risk of developing Guillain-Barré syndrome. Isolated cases of Guillain-Barré syndrome have been reported following COVID-19 vaccination but there is no proven association. There are currently no studies that show that the incidence of GBS that occurs following COVID-19 vaccination is greater than the incidence of GBS that normally occurs. Thus, there is currently no evidence to suggest that COVID-19 vaccines increase the risk of developing the syndrome above the natural incidence in a population. Cases of Guillain-Barré syndrome have been reported for different COVID-19 vaccine types. Continued surveillance of adverse events associated with COVID-19 vaccination and epidemiological studies should provide further clarity.

Click here for long answer

The content of this document is correct as of 18/05/2021.

What are the recommended physiotherapy outcome measures to use with Covid-19 patients in an out-patient post-COVID clinical setting?

Question

• What is the evidence to support high flow nasal oxygen in COVID-19 management?
• Does high flow nasal oxygen result in increased droplet dispersion and aerosol generation in COVID-19 patients?

Short Answer

High flow nasal oxygen for the management of COVID-19 is a controversial topic due to a lack of high-quality research into its efficacy and its potential as an aerosol-generating procedure. Systematic reviews commissioned by the World Health Organization found that high-flow nasal cannulas may reduce the need for invasive ventilation and the escalation of treatments over conventional oxygen therapy in COVID-19 patients. However, they caution that this potential advantage must be weighed against the currently unknown risk of droplet and aerosol transmission: there is currently no research evidence directly examining the consequent dispersion of COVID-19 virus for this procedure. A number of actions can reduce any potential risk: deliver HFNO in negative-pressure rooms and/or ensure proper ventilation; use an increased area of precaution; ensure staff have protective PPE; and place surgical masks on patients receiving the HFNO.

The content of this document is correct as of 04/12/20.

QUESTION

• Is there any evidence to suggest chest physiotherapy is an aerosol-generating procedure?
• Does the evidence compare different types of chest physiotherapy treatment techniques – and whether certain treatments may be more aerosol generating than others? (i.e. positive pressure devices, oscillating devices, cough assist, breathing techniques, patient coughing, suction etc).

SHORT ANSWER

There is insufficient evidence to state that chest physiotherapy is an aerosol-generating procedure. However, absence of evidence is not evidence of absence. International and national professional physiotherapy bodies have endorsed guidelines for physiotherapy management during COVID-19 which state that chest physiotherapy interventions are potentially aerosol-generating procedures and strongly recommend using airborne precautions when delivering these interventions. Furthermore, a recent systematic review classified chest physiotherapy interventions as potentially aerosol-generating and recommended, for the purposes of selecting personal protective equipment, that such procedures be treated as aerosol-generating.

The content of this document is correct as of 04/12/20.

Question

What is the latest evidence regarding conscious proning of COVID-19 patients?
At what level of oxygen is it best to commence proning?
When should you stop proning as the patient is improving?

Short Answer

The current evidence for conscious proning is of poor quality and fails to answer several key questions required to inform clinical practice, including the optimum conditions for commencing and ceasing proning. There are multiple RCTs underway that will address these gaps in knowledge over the coming months.

The content of this document is correct as of 27/11/2020.

Question

1.What is current guidance for cleaning a room after a hands-on physiotherapy session?

2.What are the current recommended products for effectively cleaning surfaces?

3.Do I have to wait a certain amount of time to clean my treatment room after a session?

Short answer

1.Clean with detergent and water followed by rinsing and drying. If a surface is suspected or known to have been contaminated by infectious material a disinfected should be used after cleaning.

2.A neutral detergent with water for cleaning and a chlorine-based product, such as sodium hypochlorite, for disinfecting.

3.HSPC cleaning protocols do not stipulate that a certain amount of time should be left between seeing a patient and cleaning. HSPC guidelines state that COVID-19 virus droplets produced by an infected patient will land on surfaces “within minutes” of production. They do not state how many minutes precisely. Research has found that large droplets fall within 1 second while smaller droplets can take up to 9 minutes to fall to the ground.

The content of this answer is correct as of 02/10/2020

QUESTION

• Is there a link between vaccinations for Covid-19 & developing Guillain-Barré syndrome?
• Is one type/make of vaccine a higher risk than others?

SHORT ANSWER

Currently, the available evidence does not support a link between COVID-19 vaccination and an increased risk of developing Guillain-Barré syndrome. Isolated cases of Guillain-Barré syndrome have been reported following COVID-19 vaccination but there is no proven association. There are currently no studies that show that the incidence of GBS that occurs following COVID-19 vaccination is greater than the incidence of GBS that normally occurs. Thus, there is currently no evidence to suggest that COVID-19 vaccines increase the risk of developing the syndrome above the natural incidence in a population. Cases of Guillain-Barré syndrome have been reported for different COVID-19 vaccine types. Continued surveillance of adverse events associated with COVID-19 vaccination and epidemiological studies should provide further clarity.

Click here for long answer

The content of this document is correct as of 18/05/2021.

What are the recommended physiotherapy outcome measures to use with Covid-19 patients in an out-patient post-COVID clinical setting?

Question

• What is the evidence to support high flow nasal oxygen in COVID-19 management?
• Does high flow nasal oxygen result in increased droplet dispersion and aerosol generation in COVID-19 patients?

Short Answer

High flow nasal oxygen for the management of COVID-19 is a controversial topic due to a lack of high-quality research into its efficacy and its potential as an aerosol-generating procedure. Systematic reviews commissioned by the World Health Organization found that high-flow nasal cannulas may reduce the need for invasive ventilation and the escalation of treatments over conventional oxygen therapy in COVID-19 patients. However, they caution that this potential advantage must be weighed against the currently unknown risk of droplet and aerosol transmission: there is currently no research evidence directly examining the consequent dispersion of COVID-19 virus for this procedure. A number of actions can reduce any potential risk: deliver HFNO in negative-pressure rooms and/or ensure proper ventilation; use an increased area of precaution; ensure staff have protective PPE; and place surgical masks on patients receiving the HFNO.

The content of this document is correct as of 04/12/20.

QUESTION

• Is there any evidence to suggest chest physiotherapy is an aerosol-generating procedure?
• Does the evidence compare different types of chest physiotherapy treatment techniques – and whether certain treatments may be more aerosol generating than others? (i.e. positive pressure devices, oscillating devices, cough assist, breathing techniques, patient coughing, suction etc).

SHORT ANSWER

There is insufficient evidence to state that chest physiotherapy is an aerosol-generating procedure. However, absence of evidence is not evidence of absence. International and national professional physiotherapy bodies have endorsed guidelines for physiotherapy management during COVID-19 which state that chest physiotherapy interventions are potentially aerosol-generating procedures and strongly recommend using airborne precautions when delivering these interventions. Furthermore, a recent systematic review classified chest physiotherapy interventions as potentially aerosol-generating and recommended, for the purposes of selecting personal protective equipment, that such procedures be treated as aerosol-generating.

The content of this document is correct as of 04/12/20.

Question

What is the latest evidence regarding conscious proning of COVID-19 patients?
At what level of oxygen is it best to commence proning?
When should you stop proning as the patient is improving?

Short Answer

The current evidence for conscious proning is of poor quality and fails to answer several key questions required to inform clinical practice, including the optimum conditions for commencing and ceasing proning. There are multiple RCTs underway that will address these gaps in knowledge over the coming months.

The content of this document is correct as of 27/11/2020.

Question

1.What is current guidance for cleaning a room after a hands-on physiotherapy session?

2.What are the current recommended products for effectively cleaning surfaces?

3.Do I have to wait a certain amount of time to clean my treatment room after a session?

Short answer

1.Clean with detergent and water followed by rinsing and drying. If a surface is suspected or known to have been contaminated by infectious material a disinfected should be used after cleaning.

2.A neutral detergent with water for cleaning and a chlorine-based product, such as sodium hypochlorite, for disinfecting.

3.HSPC cleaning protocols do not stipulate that a certain amount of time should be left between seeing a patient and cleaning. HSPC guidelines state that COVID-19 virus droplets produced by an infected patient will land on surfaces “within minutes” of production. They do not state how many minutes precisely. Research has found that large droplets fall within 1 second while smaller droplets can take up to 9 minutes to fall to the ground.

The content of this answer is correct as of 02/10/2020

QUESTION

• Is there a link between vaccinations for Covid-19 & developing Guillain-Barré syndrome?
• Is one type/make of vaccine a higher risk than others?

SHORT ANSWER

Currently, the available evidence does not support a link between COVID-19 vaccination and an increased risk of developing Guillain-Barré syndrome. Isolated cases of Guillain-Barré syndrome have been reported following COVID-19 vaccination but there is no proven association. There are currently no studies that show that the incidence of GBS that occurs following COVID-19 vaccination is greater than the incidence of GBS that normally occurs. Thus, there is currently no evidence to suggest that COVID-19 vaccines increase the risk of developing the syndrome above the natural incidence in a population. Cases of Guillain-Barré syndrome have been reported for different COVID-19 vaccine types. Continued surveillance of adverse events associated with COVID-19 vaccination and epidemiological studies should provide further clarity.

Click here for long answer

The content of this document is correct as of 18/05/2021.

What are the recommended physiotherapy outcome measures to use with Covid-19 patients in an out-patient post-COVID clinical setting?

Question

• What is the evidence to support high flow nasal oxygen in COVID-19 management?
• Does high flow nasal oxygen result in increased droplet dispersion and aerosol generation in COVID-19 patients?

Short Answer

High flow nasal oxygen for the management of COVID-19 is a controversial topic due to a lack of high-quality research into its efficacy and its potential as an aerosol-generating procedure. Systematic reviews commissioned by the World Health Organization found that high-flow nasal cannulas may reduce the need for invasive ventilation and the escalation of treatments over conventional oxygen therapy in COVID-19 patients. However, they caution that this potential advantage must be weighed against the currently unknown risk of droplet and aerosol transmission: there is currently no research evidence directly examining the consequent dispersion of COVID-19 virus for this procedure. A number of actions can reduce any potential risk: deliver HFNO in negative-pressure rooms and/or ensure proper ventilation; use an increased area of precaution; ensure staff have protective PPE; and place surgical masks on patients receiving the HFNO.

The content of this document is correct as of 04/12/20.

QUESTION

• Is there any evidence to suggest chest physiotherapy is an aerosol-generating procedure?
• Does the evidence compare different types of chest physiotherapy treatment techniques – and whether certain treatments may be more aerosol generating than others? (i.e. positive pressure devices, oscillating devices, cough assist, breathing techniques, patient coughing, suction etc).

SHORT ANSWER

There is insufficient evidence to state that chest physiotherapy is an aerosol-generating procedure. However, absence of evidence is not evidence of absence. International and national professional physiotherapy bodies have endorsed guidelines for physiotherapy management during COVID-19 which state that chest physiotherapy interventions are potentially aerosol-generating procedures and strongly recommend using airborne precautions when delivering these interventions. Furthermore, a recent systematic review classified chest physiotherapy interventions as potentially aerosol-generating and recommended, for the purposes of selecting personal protective equipment, that such procedures be treated as aerosol-generating.

The content of this document is correct as of 04/12/20.

Question

What is the latest evidence regarding conscious proning of COVID-19 patients?
At what level of oxygen is it best to commence proning?
When should you stop proning as the patient is improving?

Short Answer

The current evidence for conscious proning is of poor quality and fails to answer several key questions required to inform clinical practice, including the optimum conditions for commencing and ceasing proning. There are multiple RCTs underway that will address these gaps in knowledge over the coming months.

The content of this document is correct as of 27/11/2020.

Question

1.What is current guidance for cleaning a room after a hands-on physiotherapy session?

2.What are the current recommended products for effectively cleaning surfaces?

3.Do I have to wait a certain amount of time to clean my treatment room after a session?

Short answer

1.Clean with detergent and water followed by rinsing and drying. If a surface is suspected or known to have been contaminated by infectious material a disinfected should be used after cleaning.

2.A neutral detergent with water for cleaning and a chlorine-based product, such as sodium hypochlorite, for disinfecting.

3.HSPC cleaning protocols do not stipulate that a certain amount of time should be left between seeing a patient and cleaning. HSPC guidelines state that COVID-19 virus droplets produced by an infected patient will land on surfaces “within minutes” of production. They do not state how many minutes precisely. Research has found that large droplets fall within 1 second while smaller droplets can take up to 9 minutes to fall to the ground.

The content of this answer is correct as of 02/10/2020

QUESTION

• Is there a link between vaccinations for Covid-19 & developing Guillain-Barré syndrome?
• Is one type/make of vaccine a higher risk than others?

SHORT ANSWER

Currently, the available evidence does not support a link between COVID-19 vaccination and an increased risk of developing Guillain-Barré syndrome. Isolated cases of Guillain-Barré syndrome have been reported following COVID-19 vaccination but there is no proven association. There are currently no studies that show that the incidence of GBS that occurs following COVID-19 vaccination is greater than the incidence of GBS that normally occurs. Thus, there is currently no evidence to suggest that COVID-19 vaccines increase the risk of developing the syndrome above the natural incidence in a population. Cases of Guillain-Barré syndrome have been reported for different COVID-19 vaccine types. Continued surveillance of adverse events associated with COVID-19 vaccination and epidemiological studies should provide further clarity.

Click here for long answer

The content of this document is correct as of 18/05/2021.

What are the recommended physiotherapy outcome measures to use with Covid-19 patients in an out-patient post-COVID clinical setting?

Question

• What is the evidence to support high flow nasal oxygen in COVID-19 management?
• Does high flow nasal oxygen result in increased droplet dispersion and aerosol generation in COVID-19 patients?

Short Answer

High flow nasal oxygen for the management of COVID-19 is a controversial topic due to a lack of high-quality research into its efficacy and its potential as an aerosol-generating procedure. Systematic reviews commissioned by the World Health Organization found that high-flow nasal cannulas may reduce the need for invasive ventilation and the escalation of treatments over conventional oxygen therapy in COVID-19 patients. However, they caution that this potential advantage must be weighed against the currently unknown risk of droplet and aerosol transmission: there is currently no research evidence directly examining the consequent dispersion of COVID-19 virus for this procedure. A number of actions can reduce any potential risk: deliver HFNO in negative-pressure rooms and/or ensure proper ventilation; use an increased area of precaution; ensure staff have protective PPE; and place surgical masks on patients receiving the HFNO.

The content of this document is correct as of 04/12/20.

QUESTION

• Is there any evidence to suggest chest physiotherapy is an aerosol-generating procedure?
• Does the evidence compare different types of chest physiotherapy treatment techniques – and whether certain treatments may be more aerosol generating than others? (i.e. positive pressure devices, oscillating devices, cough assist, breathing techniques, patient coughing, suction etc).

SHORT ANSWER

There is insufficient evidence to state that chest physiotherapy is an aerosol-generating procedure. However, absence of evidence is not evidence of absence. International and national professional physiotherapy bodies have endorsed guidelines for physiotherapy management during COVID-19 which state that chest physiotherapy interventions are potentially aerosol-generating procedures and strongly recommend using airborne precautions when delivering these interventions. Furthermore, a recent systematic review classified chest physiotherapy interventions as potentially aerosol-generating and recommended, for the purposes of selecting personal protective equipment, that such procedures be treated as aerosol-generating.

The content of this document is correct as of 04/12/20.

Question

What is the latest evidence regarding conscious proning of COVID-19 patients?
At what level of oxygen is it best to commence proning?
When should you stop proning as the patient is improving?

Short Answer

The current evidence for conscious proning is of poor quality and fails to answer several key questions required to inform clinical practice, including the optimum conditions for commencing and ceasing proning. There are multiple RCTs underway that will address these gaps in knowledge over the coming months.

The content of this document is correct as of 27/11/2020.

Question

1.What is current guidance for cleaning a room after a hands-on physiotherapy session?

2.What are the current recommended products for effectively cleaning surfaces?

3.Do I have to wait a certain amount of time to clean my treatment room after a session?

Short answer

1.Clean with detergent and water followed by rinsing and drying. If a surface is suspected or known to have been contaminated by infectious material a disinfected should be used after cleaning.

2.A neutral detergent with water for cleaning and a chlorine-based product, such as sodium hypochlorite, for disinfecting.

3.HSPC cleaning protocols do not stipulate that a certain amount of time should be left between seeing a patient and cleaning. HSPC guidelines state that COVID-19 virus droplets produced by an infected patient will land on surfaces “within minutes” of production. They do not state how many minutes precisely. Research has found that large droplets fall within 1 second while smaller droplets can take up to 9 minutes to fall to the ground.

The content of this answer is correct as of 02/10/2020